Literature DB >> 7517825

Acute effects of tramadol in methadone-maintained volunteers.

J Camí1, X Lamas, M Farré.   

Abstract

The opioid agonist and antagonist properties of tramadol were assessed in 6 male opioid-dependent volunteers enrolled in a methadone maintenance programme. Subjects participated in 3 experimental sessions in which the effects of intramuscular tramadol 100 and 300 mg and placebo were evaluated. Tramadol neither produced morphine-like effects nor precipitated a withdrawal syndrome; its subjective, behavioural and physiological effects were not different from those of placebo. Although the results of this study suggest that tramadol has a low abuse liability in opioid-dependent subjects, higher doses should be tested to confirm these data.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7517825     DOI: 10.2165/00003495-199400471-00007

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  11 in total

1.  Methods for evaluating addiction liability. (A) "Attitude" of opiate addicts toward opiate-like drugs. (B) a short-term "direct" addiction test.

Authors:  H F FRASER; G D VAN HORN; W R MARTIN; A B WOLBACH; H ISBELL
Journal:  J Pharmacol Exp Ther       Date:  1961-09       Impact factor: 4.030

2.  Human drug abuse liability assessment: opioids and analgesics.

Authors:  G E Bigelow
Journal:  Br J Addict       Date:  1991-12

Review 3.  Pharmacokinetic considerations in abuse liability evaluation.

Authors:  M Farré; J Camí
Journal:  Br J Addict       Date:  1991-12

4.  Drug dependence potential of 1-(m-methoxyphenyl)-2-dimethylaminomethyl)-cyclohexan-1-ol hydrochloride (tramadol) tested in monkeys.

Authors:  T Yanagita
Journal:  Arzneimittelforschung       Date:  1978

5.  Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man.

Authors:  W R Martin; J W Sloan; J D Sapira; D R Jasinski
Journal:  Clin Pharmacol Ther       Date:  1971 Mar-Apr       Impact factor: 6.875

6.  Abuse potential and pharmacological comparison of tramadol and morphine.

Authors:  K L Preston; D R Jasinski; M Testa
Journal:  Drug Alcohol Depend       Date:  1991-01       Impact factor: 4.492

Review 7.  Tramadol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in acute and chronic pain states.

Authors:  C R Lee; D McTavish; E M Sorkin
Journal:  Drugs       Date:  1993-08       Impact factor: 9.546

8.  Measurement of recovery from outpatient general anaesthesia with a simple ocular test.

Authors:  J G Hannington-Kiff
Journal:  Br Med J       Date:  1970-07-18

9.  Clinical investigation on the development of dependence during oral therapy with tramadol.

Authors:  W Richter; H Barth; L Flohé; H Giertz
Journal:  Arzneimittelforschung       Date:  1985

10.  Opioid and nonopioid components independently contribute to the mechanism of action of tramadol, an 'atypical' opioid analgesic.

Authors:  R B Raffa; E Friderichs; W Reimann; R P Shank; E E Codd; J L Vaught
Journal:  J Pharmacol Exp Ther       Date:  1992-01       Impact factor: 4.030

View more
  15 in total

1.  Effects of repeated tramadol and morphine administration on psychomotor and cognitive performance in opioid-dependent volunteers.

Authors:  Miriam Z Mintzer; Ryan K Lanier; Michelle R Lofwall; George E Bigelow; Eric C Strain
Journal:  Drug Alcohol Depend       Date:  2010-06-09       Impact factor: 4.492

Review 2.  Tramadol analgesia. Synergy in research and therapy.

Authors:  J M Besson; M D Vickers
Journal:  Drugs       Date:  1994       Impact factor: 9.546

3.  All-Cause Mortality Associated with Tramadol Use: A Case-Crossover Study.

Authors:  Sohyun Jeong; Ha Jin Tchoe; Junqing Li; Ju-Young Shin
Journal:  Drug Saf       Date:  2019-06       Impact factor: 5.606

4.  The effects of tramadol on static and dynamic pupillometry in healthy subjects--the relationship between pharmacodynamics, pharmacokinetics and CYP2D6 metaboliser status.

Authors:  Frank Fliegert; Burkhard Kurth; Karin Göhler
Journal:  Eur J Clin Pharmacol       Date:  2005-05-20       Impact factor: 2.953

5.  Physical dependence potential of daily tramadol dosing in humans.

Authors:  Ryan K Lanier; Michelle R Lofwall; Miriam Z Mintzer; George E Bigelow; Eric C Strain
Journal:  Psychopharmacology (Berl)       Date:  2010-06-30       Impact factor: 4.530

Review 6.  Clinical pharmacology of tramadol.

Authors:  Stefan Grond; Armin Sablotzki
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

Review 7.  A risk-benefit assessment of tramadol in the management of pain.

Authors:  L Radbruch; S Grond; K A Lehmann
Journal:  Drug Saf       Date:  1996-07       Impact factor: 5.606

8.  Discriminative stimulus effects of tramadol in humans.

Authors:  Angela N Duke; George E Bigelow; Ryan K Lanier; Eric C Strain
Journal:  J Pharmacol Exp Ther       Date:  2011-04-05       Impact factor: 4.030

9.  Abuse liability and reinforcing efficacy of oral tramadol in humans.

Authors:  Shanna Babalonis; Michelle R Lofwall; Paul A Nuzzo; Anthony J Siegel; Sharon L Walsh
Journal:  Drug Alcohol Depend       Date:  2012-10-23       Impact factor: 4.492

Review 10.  Abuse liability, behavioral pharmacology, and physical-dependence potential of opioids in humans and laboratory animals: lessons from tramadol.

Authors:  David H Epstein; Kenzie L Preston; Donald R Jasinski
Journal:  Biol Psychol       Date:  2006-02-23       Impact factor: 3.251

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.